Journal of AdvancedMedical and Dental Sciences Research

Aim: The purpose of this study is to assess the acute symptoms of chronic obstructive pulmonary disease (COPD). Methods: This research included all participants who had been hospitalised for COPD exacerbations. In this research, we classified COPD exacerbations as patients hospitalised with a main diagnosis of COPD or those admitted with a primary diagnosis of pneumonia and a secondary diagnosis of COPD. In-hospital mortality and one-year mortality following discharge were the outcomes of interest. Demographics, comorbid conditions, concomitant drugs, and COPD treatments are all discussed. COPD-related drugs, including as short- and long-acting b2 agonists, anticholinergics, inhaled corticosteroids, and theophyllines, were assessed in the six months before the first hospitalisation. Results: The average age of the overall population at the time of cohort entrance was 75.5 years, with 67.5 percent of them being male. The majority of the patients had comorbidities, with a Charlson comorbidity index score of 3.8. Hypertension (56.25 percent), coronary artery disease (32.5 percent), and stroke were the most often seen comorbidities (32.5 percent ). Approximately three-fourths of the patients were put on #2 COPD drugs, and 80 percent of patients had #2 emergency visits for COPD. The average hospital stay was 13.5±15 days. 12.5 percent of patients were admitted to the ICU, with a 9-day average stay. Mechanical breathing was necessary in 7.5 percent of patients, with a median duration of 8 days. Non-invasive ventilation was used in 2.5 percent of the patients. During the index hospitalisation, 9 patients (11.25 percent) died. Nonsurvivors were older than survivors and had a higher Charlson comorbidity index score. Conclusion: In conclusion, even if it is the first-ever exacerbation necessitating hospitalisation, it predicts a bad long-term result in COPD patients.